Optimizing Response in Psychosis Study

NCT00314327 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Recruitment for the study was limited.

Conditions

Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Psychotic Disorder Not Otherwise Specified

Interventions

DRUG: long-acting injectable risperidone

Sponsor

Northwell Health

Collaborators

[object Object]
[object Object]